Peptides Similar to Cortistatin
Compare Cortistatin with related peptides and alternatives
📌TL;DR
- •1 similar peptides identified
- •Oveporexton: Low - Both relate to sleep neurobiology, but cortistatin promotes slow-wave sleep while oveporexton promotes wakefulness for narcolepsy
Quick Comparison
| Peptide | Similarity | Key Differences |
|---|---|---|
| Cortistatin (current) | - | - |
| Oveporexton | Low - Both relate to sleep neurobiology, but cortistatin promotes slow-wave sleep while oveporexton promotes wakefulness for narcolepsy | Cortistatin is an endogenous neuropeptide that enhances slow-wave sleep. Oveporexton is a synthetic small molecule that activates OX2R to promote wakefulness. They target different aspects of sleep-wake regulation. |
Peptides Related to Cortistatin#
Cortistatin occupies a unique niche as both a sleep-promoting neuropeptide and a potent anti-inflammatory factor. Its structural homology with somatostatin and unique ghrelin receptor binding make comparisons with several peptide families relevant.
Somatostatin (SST-14)#
Somatostatin-14 is cortistatin's closest structural relative, sharing 11 of 14 amino acid residues.
Structural comparison: Both are cyclic 14-amino-acid peptides with an intramolecular disulfide bond. The core FWKTFTSC motif is conserved. However, they are encoded by separate genes on different chromosomes.
Receptor comparison: Both bind all five somatostatin receptors (sst1-5) with comparable affinity. The key difference is that cortistatin uniquely activates the ghrelin receptor (GHSR-1a) and MrgX2, which somatostatin does not.
Functional comparison: Somatostatin is widely expressed throughout the brain and periphery and functions primarily as an inhibitory hormone (suppressing GH, insulin, glucagon, and gastric acid). Cortistatin is cortex-restricted in the brain and has distinct functions in sleep promotion and immune regulation that somatostatin does not share.
| Feature | Cortistatin-14 | Somatostatin-14 |
|---|---|---|
| Sequence | PCKNFFWKTFSSCK | AGCKNFFWKTFTSC |
| Gene | CORT (chromosome 1) | SST (chromosome 3) |
| CNS expression | Cortex/hippocampus only | Widespread |
| Sleep effects | Promotes slow-wave sleep | No direct sleep effects |
| GHSR-1a binding | Yes | No |
| Anti-inflammatory | Potent | Modest |
| Hormonal inhibition | Yes (via sst receptors) | Yes (primary function) |
Ghrelin#
Ghrelin is a 28-amino-acid peptide that is the endogenous ligand for GHSR-1a, the receptor that cortistatin uniquely shares.
Receptor overlap: Both cortistatin and ghrelin activate GHSR-1a, but through different binding sites and with different functional consequences. Ghrelin activates GHSR-1a in the hypothalamus to stimulate appetite and GH release, while cortistatin's GHSR-1a activation may contribute to its immune-modulatory effects.
Functional differences: Ghrelin is primarily a hunger hormone and GH secretagogue, while cortistatin is a sleep-promoting and anti-inflammatory neuropeptide. Their shared GHSR-1a activation creates complex pharmacological interactions.
Orexin-A and Orexin-B#
The orexin neuropeptides (orexin-A, 33 amino acids; orexin-B, 28 amino acids) are wake-promoting neuropeptides that function in opposition to cortistatin's sleep-promoting effects.
Sleep-wake axis: Cortistatin promotes slow-wave sleep by enhancing EEG synchronization and opposing cholinergic arousal. Orexins promote wakefulness by activating OX1R and OX2R on arousal-promoting neurons. Together, they represent complementary arms of the sleep-wake regulatory system.
Clinical development: Orexin biology has been successfully targeted clinically through both antagonists (suvorexant, lemborexant for insomnia) and agonists (oveporexton for narcolepsy), while cortistatin-based therapeutics remain preclinical.
Vasoactive Intestinal Peptide (VIP)#
VIP is another neuropeptide with both neurological and anti-inflammatory properties.
Anti-inflammatory comparison: Both cortistatin and VIP suppress pro-inflammatory cytokines, promote Treg generation, and show therapeutic efficacy in IBD and arthritis models. They appear to act through complementary but distinct receptor pathways.
Clinical relevance: Neither has progressed to clinical development for inflammatory indications, though both have robust preclinical evidence bases.
Summary Comparison#
| Feature | Cortistatin | Somatostatin | Ghrelin | Orexins |
|---|---|---|---|---|
| Sleep effects | Promotes SWS | None | Modulates sleep architecture | Promotes wakefulness |
| Anti-inflammatory | Potent | Modest | Modest | Minimal |
| sst receptor binding | Yes (all 5) | Yes (all 5) | No | No |
| GHSR-1a binding | Yes | No | Yes (primary) | No |
| OX receptor binding | No | No | No | Yes (primary) |
| Clinical development | None | Approved analogs | Approved analogs | Antagonists and agonists approved/NDA |
| Expression | Cortex/hippocampus | Widespread | Stomach/hypothalamus | Lateral hypothalamus |
Related Reading#
Frequently Asked Questions About Cortistatin
What are the main alternatives to Cortistatin?
The primary alternatives to Cortistatin include Oveporexton. Each has a different mechanism of action and evidence profile. The choice between them depends on the specific research objectives.
How does Cortistatin compare to Oveporexton?
Low - Both relate to sleep neurobiology, but cortistatin promotes slow-wave sleep while oveporexton promotes wakefulness for narcolepsy. Key differences: Cortistatin is an endogenous neuropeptide that enhances slow-wave sleep. Oveporexton is a synthetic small molecule that activates OX2R to promote wakefulness. They target different aspects of sleep-wake regulation.. Advantages of Oveporexton: Oveporexton has completed Phase 3 trials and has NDA filed with Priority Review for narcolepsy type 1. Disadvantages: Oveporexton addresses narcolepsy only; does not have cortistatin's anti-inflammatory properties; synthetic small molecule rather than endogenous neuropeptide.
Can Cortistatin be combined with other peptides?
Some research protocols study Cortistatin in combination with related peptides such as Oveporexton. However, combination studies are limited and no established guidelines exist for combining these peptides. Any combination use should be guided by available research data.
Explore Further
Disclaimer: For educational purposes only. Not medical advice. Read full disclaimer